Italy · Medical devices startup
Italy · Prothea Technologies
Prothea Technologies is a private medical technology company based in the United Kingdom.
Funding reportedLast round: Series A
Follow Prothea Technologies and see its new rounds in your feed.Start following
About Prothea Technologies
Prothea Technologies is a private medical technology company based in the United Kingdom.
It specializes in an integrated platform designed for lung cancer biopsy, diagnosis, and treatment, all within a single hospital visit. This innovative approach significantly reduces the time-to-treat from weeks to minutes, addressing delays and inaccuracies in traditional workflows for patients with suspected early-stage lung cancer. Founded in April 2024 as a spinout from the Universities of Bath and Edinburgh, Prothea has secured €12M ($13M) in Series A funding. The company employs a team of 11-20 people and has an estimated annual revenue of $1.6M. Its core technology features a medical device that combines a Microendoscope with an Image Processing System, allowing for real-time visualization of tissue structure during biopsy. This technology is enhanced by proprietary AI software that provides insights during procedures. Prothea is also developing future solutions, including a laser ablation catheter for immediate treatment of lesions.
What company datasets say Prothea Technologies raised
Funding, as reported
Founders and team
From Prothea Technologies's own website: 17 on the team.
- Anne MooreChief Operating & Finance Officer
- Jim StoneChief Technical Officer
- Professor Kev DhaliwalChief Medical and Chief Scientific Officer
- Annya BruceHead of Clinical Affairs
- Charlotte ParryHead of Fibre Engineering
- Fabian KlarnerVP Engineering, Manging Director Prothea Technologies GmbH
- Gareth WilliamsVP Systems Research and Development
- Harry WoodHead of Fibre
- Hazel StewartHead of Systems Engineering
- Joel CollinsHead of Software
- Qiang WangHead of Artificial Intelligence R&D
- Vikki YoungVP Regulatory & Quality Affairs
- Crispin SimonExecutive Chair
- Hilola HakimovaQuality Manager
- John YianniNon-Executive Director
- Peter StratfordNon-Executive Director
- Yoann BonnamourNon-Executive Director
On a portfolio page
Investors who name them
Each firm lists Prothea Technologies on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
The company, in detail
What they build
Known for
health carebiopsy systemreal-time imagingreal-time biopsy guidancemanufacturingfluorescence lifetime imagingmedical researchmedical equipment manufacturingtissue characterizationmicroendoscopemolecular analysishospital & health careregulatory developmentoptical endomicroscopyin situ tissue analysishealth
Built with from their website
Google MapsLiteSpeedWordPress.orgFont AwesomeMailChimpCloudFlareViewport MetaVarnishApple Business ManagerGoogle Maps Platform
+8 more
CloudFlare CDNOWL CarouselPriority HintsGoogle Font APIMicrosoft ExchangeAutodeskCloudflare InsightsMySQL
- Sector
- Medical devices
- Industry code
- NAICS 339112, SIC 3844
- Region
- Lombardy
Medical devices in Italy
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Prothea Technologies in front of investors. Or tell us what we have wrong.